SPX5,611.85+30.91 0.55%
DIA419.88+4.26 1.03%
IXIC17,299.29-23.70 -0.14%

Ascendiant Capital Maintains Buy on IGC Pharma, Raises Price Target to $4.25

Benzinga·02/24/2025 12:52:31
Listen to the news
Ascendiant Capital analyst Edward Woo maintains IGC Pharma (AMEX:IGC) with a Buy and raises the price target from $4 to $4.25.